Stoke Therapeutics, Inc. short interest in 2023
In 2023, Stoke Therapeutics, Inc.'s disclosed short interest ran from 9.79% of shares outstanding on 13 Jan 2023 to 7.44% on 29 Dec 2023, a change of -2.35 percentage points. The year's high was 12.94% on 30 Jun 2023 and its low 7.15% on 15 Dec 2023, averaging 10.35% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 40.20 days on 14 Jul 2023. Full history: Stoke Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 9.79% (13 Jan 2023)
- End of year
- 7.44% (29 Dec 2023)
- Change
- -2.35 pp
- High
- 12.94% (30 Jun 2023)
- Low
- 7.15% (15 Dec 2023)
- Average
- 10.35%
- Highest days to cover
- 40.20 (14 Jul 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 9.79% | 7.33 | |
| 31 Jan 2023 | 9.69% | 34.29 | |
| 15 Feb 2023 | 9.85% | 6.30 | |
| 28 Feb 2023 | 9.85% | 22.77 | |
| 15 Mar 2023 | 9.99% | 12.99 | 10-K filed, results (8-K) |
| 31 Mar 2023 | 10.84% | 13.89 | |
| 14 Apr 2023 | 9.90% | 25.16 | |
| 28 Apr 2023 | 10.67% | 23.58 | |
| 15 May 2023 | 11.05% | 19.15 | 10-Q filed, results (8-K) |
| 31 May 2023 | 11.83% | 39.10 | |
| 15 Jun 2023 | 12.36% | 18.82 | |
| 30 Jun 2023 | 12.94% | 12.61 | |
| 14 Jul 2023 | 12.92% | 40.20 | |
| 31 Jul 2023 | 12.42% | 5.28 | |
| 15 Aug 2023 | 10.07% | 8.81 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 10.47% | 23.98 | |
| 15 Sep 2023 | 10.77% | 19.14 | |
| 29 Sep 2023 | 10.38% | 21.44 | |
| 13 Oct 2023 | 10.21% | 17.07 | |
| 31 Oct 2023 | 9.65% | 27.74 | |
| 15 Nov 2023 | 9.14% | 21.56 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 9.01% | 21.57 | |
| 15 Dec 2023 | 7.15% | 11.10 | |
| 29 Dec 2023 | 7.44% | 11.81 |
See also: Stoke Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.